Kongsaengdao, S.; Arayawithchanont, A.; Samintharapanya, K.; Rojanapitayakorn, P.; Maneeton, B.; Maneeton, N.
Low-Dose Neubotulinum Toxin A versus Low-Dose Abobotulinum Toxin A Injection for the Treatment of Cervical Dystonia: A Multicenter, 48-Week, Prospective, Double-Blinded, Randomized Crossover Design Study. Toxins 2021, 13, 694.
https://doi.org/10.3390/toxins13100694
AMA Style
Kongsaengdao S, Arayawithchanont A, Samintharapanya K, Rojanapitayakorn P, Maneeton B, Maneeton N.
Low-Dose Neubotulinum Toxin A versus Low-Dose Abobotulinum Toxin A Injection for the Treatment of Cervical Dystonia: A Multicenter, 48-Week, Prospective, Double-Blinded, Randomized Crossover Design Study. Toxins. 2021; 13(10):694.
https://doi.org/10.3390/toxins13100694
Chicago/Turabian Style
Kongsaengdao, Subsai, Arkhom Arayawithchanont, Kanoksri Samintharapanya, Pichai Rojanapitayakorn, Benchalak Maneeton, and Narong Maneeton.
2021. "Low-Dose Neubotulinum Toxin A versus Low-Dose Abobotulinum Toxin A Injection for the Treatment of Cervical Dystonia: A Multicenter, 48-Week, Prospective, Double-Blinded, Randomized Crossover Design Study" Toxins 13, no. 10: 694.
https://doi.org/10.3390/toxins13100694
APA Style
Kongsaengdao, S., Arayawithchanont, A., Samintharapanya, K., Rojanapitayakorn, P., Maneeton, B., & Maneeton, N.
(2021). Low-Dose Neubotulinum Toxin A versus Low-Dose Abobotulinum Toxin A Injection for the Treatment of Cervical Dystonia: A Multicenter, 48-Week, Prospective, Double-Blinded, Randomized Crossover Design Study. Toxins, 13(10), 694.
https://doi.org/10.3390/toxins13100694
